These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9259004)

  • 1. Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats.
    McMahon LR; Wellman PJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):767-70. PubMed ID: 9259004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the involvement of paraventricular hypothalamic alpha 2-adrenoceptors in phenylpropanolamine anorexia.
    Davies BT; Wellman PJ; Morien A
    Physiol Behav; 1993 Jul; 54(1):121-8. PubMed ID: 8392206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the alpha 1a-adrenoceptor antagonist RS-17053 on phenylpropanolamine-induced anorexia in rats.
    Wellman PJ; McMahon LR; Green T; Tole A
    Pharmacol Biochem Behav; 1997; 57(1-2):281-4. PubMed ID: 9164583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus.
    McMahon LR; Wellman PJ
    Physiol Behav; 1996 Jan; 59(1):63-9. PubMed ID: 8848492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of phenylpropanolamine anorexia in rats by the alpha-1 receptor antagonist benoxathian.
    Wellman PJ; Davies BT
    Pharmacol Biochem Behav; 1991 Apr; 38(4):905-8. PubMed ID: 1678528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist prazosin.
    Wellman PJ; Davies BT
    Pharmacol Biochem Behav; 1992 May; 42(1):97-100. PubMed ID: 1356275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.
    Hsieh YS; Kuo MH; Chen PN; Kuo DY
    Neuromolecular Med; 2013 Mar; 15(1):159-68. PubMed ID: 23179670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of phenylpropanolamine anorexia by proglumide in rats.
    Wellman PJ; Tow S
    Appetite; 1991 Apr; 16(2):121-7. PubMed ID: 2064390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats.
    Wellman PJ; Tow S; McMahon L
    Pharmacol Biochem Behav; 1995 Feb; 50(2):287-91. PubMed ID: 7740069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of involvement of 4-hydroxynorephedrine in phenylpropanolamine-induced anorexia in rats.
    Rushing PA; Mittleman G
    Physiol Behav; 1993 Nov; 54(5):927-30. PubMed ID: 8248385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of adrenergic anorectic agents.
    Wellman PJ
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):193S-198S. PubMed ID: 1309478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nitric oxide synthase enhances the myocardial toxicity of phenylpropanolamine.
    Zaloga GP; Clark JD; Roberts PR
    Crit Care Med; 2000 Nov; 28(11):3679-83. PubMed ID: 11098973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intra-PVN injections of d- and l-norephedrine on feeding in rats.
    Wellman PJ; DiCarlo B; Morien A; Davies BT
    Brain Res Bull; 1993; 32(4):443-5. PubMed ID: 8221134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of haloperidol on anorexia induced by l-norephedrine and d-amphetamine in adult rats.
    Wellman PJ
    Pharmacol Biochem Behav; 1990 Feb; 35(2):457-60. PubMed ID: 2320655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    J Neurochem; 2008 Jan; 104(1):50-61. PubMed ID: 17868324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y (NPY) in phenylpropranolamine-mediated appetite suppression.
    Hsieh YS; Hsu JD; Yang SF; Kuo DY
    Peptides; 2004 Dec; 25(12):2155-61. PubMed ID: 15572205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss induced by chronic phenylpropanolamine: anorexia and brown adipose tissue thermogenesis.
    Wellman PJ; Sellers TL
    Pharmacol Biochem Behav; 1986 Mar; 24(3):605-11. PubMed ID: 3703896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both alpha1-adrenergic and D(1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice.
    Cheng JT; Kuo DY
    Neurosci Lett; 2003 Aug; 347(2):136-8. PubMed ID: 12873745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.